|
1
|
Snijders RJALM, Stoelinga AEC, van Hoek B, Drenth JPH. Reply to: Comments on "An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis". J Hepatol 2024; 81:e43-e44. [PMID: 38554845 DOI: 10.1016/j.jhep.2024.03.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/19/2024] [Accepted: 03/21/2024] [Indexed: 04/02/2024]
Affiliation(s)
- Romée J A L M Snijders
- Department of Gastroenterology and Hepatology, Radboudumc, Nijmegen, the Netherlands; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Germany.
| | - Anna E C Stoelinga
- Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands
| | - Bart van Hoek
- Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands
| | - Joost P H Drenth
- Department of Gastroenterology and Hepatology, Amsterdam University Medical Centres, Amsterdam, The Netherlands; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Germany
| |
Collapse
|